APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Infective Ophthalmic

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Selected research

Industry Growth & Trends

Global Anti-Infective Ophthalmic Industry Growth and Trends Forecast to 2032

23 December 202598 pages

Choose your research edition.

Industry ResearchAnti-Infective Ophthalmic Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Infective Ophthalmic Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Anti-Infective Ophthalmic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Infective Ophthalmic Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Infective Ophthalmic Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Anti-Infective Ophthalmic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Infective Ophthalmic market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Infective Ophthalmic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Infective Ophthalmic.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Infective Ophthalmic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Infective Ophthalmic Market by Company

Novartis

Allergan

Valeant Pharmaceuticals

Santen Pharmaceutical

Lupin Pharmaceuticals

Apotex

Akorn

Anti-Infective Ophthalmic Segment by Type

Antibacterial

Antiviral

Antifungal

Anti-Parasitic

Others

Anti-Infective Ophthalmic Segment by Application

Hospital

Clinic

Household

Others

Anti-Infective Ophthalmic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Ophthalmic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Ophthalmic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Ophthalmic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Infective Ophthalmic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Infective Ophthalmic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibacterial Table 2. Major Company of Antiviral Table 3. Major Company of Antifungal Table 4. Major Company of Anti-Parasitic Table 5. Major Company of Others Table 6. Global Anti-Infective Ophthalmic Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 8. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti-Infective Ophthalmic Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti-Infective Ophthalmic Price by Type (2021-2026) & (USD/Unit) Table 12. Global Anti-Infective Ophthalmic Sales by Type (2027-2032) & (K Units) Table 13. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti-Infective Ophthalmic Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti-Infective Ophthalmic Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti-Infective Ophthalmic Price by Type (2027-2032) & (USD/Unit) Table 17. North America Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 18. North America Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 20. Europe Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 24. Latin America Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti-Infective Ophthalmic Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Anti-Infective Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 27. Anti-Infective Ophthalmic Industry Trends Table 28. Anti-Infective Ophthalmic Industry Drivers Table 29. Anti-Infective Ophthalmic Industry Opportunities and Challenges Table 30. Anti-Infective Ophthalmic Industry Restraints Table 31. Global Anti-Infective Ophthalmic Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti-Infective Ophthalmic Revenue Market Share by Company (2021-2026) Table 33. Global Anti-Infective Ophthalmic Sales by Company (2021-2026) & (K Units) Table 34. Global Anti-Infective Ophthalmic Sales Share by Company (2021-2026) Table 35. Global Anti-Infective Ophthalmic Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Anti-Infective Ophthalmic Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti-Infective Ophthalmic Major Company Production Sites and Headquarters Table 38. Global Anti-Infective Ophthalmic Company, Product Type & Application Table 39. Global Anti-Infective Ophthalmic Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti-Infective Ophthalmic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti-Infective Ophthalmic Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti-Infective Ophthalmic Sales by Region (2021-2026) & (K Units) Table 44. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti-Infective Ophthalmic Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti-Infective Ophthalmic Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti-Infective Ophthalmic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Anti-Infective Ophthalmic Sales by Region (2027-2032) & (K Units) Table 49. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti-Infective Ophthalmic Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti-Infective Ophthalmic Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti-Infective Ophthalmic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Anti-Infective Ophthalmic Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 55. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti-Infective Ophthalmic Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti-Infective Ophthalmic Price by Application (2021-2026) & (USD/Unit) Table 59. Global Anti-Infective Ophthalmic Sales by Application (2027-2032) & (K Units) Table 60. Global Anti-Infective Ophthalmic Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti-Infective Ophthalmic Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti-Infective Ophthalmic Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti-Infective Ophthalmic Price by Application (2027-2032) & (USD/Unit) Table 64. North America Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 65. North America Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 67. Europe Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 71. Latin America Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti-Infective Ophthalmic Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Anti-Infective Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Novartis Anti-Infective Ophthalmic Product Portfolio Table 78. Novartis Recent Development Table 79. Allergan Company Information Table 80. Allergan Business Overview Table 81. Allergan Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Allergan Anti-Infective Ophthalmic Product Portfolio Table 83. Allergan Recent Development Table 84. Valeant Pharmaceuticals Company Information Table 85. Valeant Pharmaceuticals Business Overview Table 86. Valeant Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Valeant Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio Table 88. Valeant Pharmaceuticals Recent Development Table 89. Santen Pharmaceutical Company Information Table 90. Santen Pharmaceutical Business Overview Table 91. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolio Table 93. Santen Pharmaceutical Recent Development Table 94. Lupin Pharmaceuticals Company Information Table 95. Lupin Pharmaceuticals Business Overview Table 96. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio Table 98. Lupin Pharmaceuticals Recent Development Table 99. Apotex Company Information Table 100. Apotex Business Overview Table 101. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Apotex Anti-Infective Ophthalmic Product Portfolio Table 103. Apotex Recent Development Table 104. Akorn Company Information Table 105. Akorn Business Overview Table 106. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Akorn Anti-Infective Ophthalmic Product Portfolio Table 108. Akorn Recent Development Table 109. North America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. North America Anti-Infective Ophthalmic Sales by Country (2021-2026) & (K Units) Table 111. North America Anti-Infective Ophthalmic Sales Market Share by Country (2021-2026) Table 112. North America Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032) & (K Units) Table 113. North America Anti-Infective Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 114. North America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Anti-Infective Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Anti-Infective Ophthalmic Market Share by Country (2021-2026) Table 117. North America Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Anti-Infective Ophthalmic Market Share Forecast by Country (2027-2032) Table 119. Europe Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Europe Anti-Infective Ophthalmic Sales by Country (2021-2026) & (K Units) Table 121. Europe Anti-Infective Ophthalmic Sales Market Share by Country (2021-2026) Table 122. Europe Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032) & (K Units) Table 123. Europe Anti-Infective Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Anti-Infective Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Anti-Infective Ophthalmic Market Share by Country (2021-2026) Table 127. Europe Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Anti-Infective Ophthalmic Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Anti-Infective Ophthalmic Sales by Country (2021-2026) & (K Units) Table 131. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032) & (K Units) Table 133. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Anti-Infective Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Anti-Infective Ophthalmic Market Share by Country (2021-2026) Table 137. Asia-Pacific Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Anti-Infective Ophthalmic Market Share Forecast by Country (2027-2032) Table 139. Latin America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Latin America Anti-Infective Ophthalmic Sales by Country (2021-2026) & (K Units) Table 141. Latin America Anti-Infective Ophthalmic Sales Market Share by Country (2021-2026) Table 142. Latin America Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032) & (K Units) Table 143. Latin America Anti-Infective Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Anti-Infective Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Anti-Infective Ophthalmic Market Share by Country (2021-2026) Table 147. Latin America Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Anti-Infective Ophthalmic Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2021-2026) & (K Units) Table 151. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032) & (K Units) Table 153. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Anti-Infective Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Anti-Infective Ophthalmic Market Share by Country (2021-2026) Table 157. Middle East and Africa Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Anti-Infective Ophthalmic Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Anti-Infective Ophthalmic Distributors List Table 162. Anti-Infective Ophthalmic Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Anti-Infective Ophthalmic Image Figure 2. Global Anti-Infective Ophthalmic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Infective Ophthalmic Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Infective Ophthalmic Sales (2021-2032) & (K Units) Figure 5. Antibacterial Image Figure 6. Global Antibacterial Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antiviral Image Figure 8. Global Antiviral Sales YoY Growth (2021-2032) & (K Units) Figure 9. Antifungal Image Figure 10. Global Antifungal Sales YoY Growth (2021-2032) & (K Units) Figure 11. Anti-Parasitic Image Figure 12. Global Anti-Parasitic Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Anti-Infective Ophthalmic Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti-Infective Ophthalmic Market Share by Type 2025 VS 2032 Figure 17. North America Anti-Infective Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti-Infective Ophthalmic Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti-Infective Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti-Infective Ophthalmic Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti-Infective Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti-Infective Ophthalmic Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti-Infective Ophthalmic Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Household Image Figure 34. Global Household Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Anti-Infective Ophthalmic Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Anti-Infective Ophthalmic Market Share by Application 2025 VS 2032 Figure 39. North America Anti-Infective Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 40. North America Anti-Infective Ophthalmic Sales Market Share in Value by Application in 2025 Figure 41. Europe Anti-Infective Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 42. Europe Anti-Infective Ophthalmic Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Anti-Infective Ophthalmic Sales Market Share in Value by Application in 2025 Figure 45. Latin America Anti-Infective Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Anti-Infective Ophthalmic Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share in Value by Application in 2025 Figure 49. North America Anti-Infective Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Anti-Infective Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Anti-Infective Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti-Infective Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Anti-Infective Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Anti-Infective Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti-Infective Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Anti-Infective Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Anti-Infective Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti-Infective Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Anti-Infective Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Anti-Infective Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti-Infective Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Anti-Infective Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Anti-Infective Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Anti-Infective Ophthalmic Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Anti-Infective Ophthalmic Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Antibacterial
  • Antiviral
  • Antifungal
  • Anti-Parasitic
  • Others
Applications
  • Hospital
  • Clinic
  • Household
  • Others
Companies covered
  • Novartis
  • Allergan
  • Valeant Pharmaceuticals
  • Santen Pharmaceutical
  • Lupin Pharmaceuticals
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Infective Ophthalmic Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Infective Ophthalmic Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Infective Ophthalmic Market by Type
  6. 1.3.1 Antibacterial
  7. 1.3.2 Antiviral
  8. 1.3.3 Antifungal
  9. 1.3.4 Anti-Parasitic
  10. 1.3.5 Others
  11. 1.4 Global Anti-Infective Ophthalmic Market Size by Type
  12. 1.4.1 Global Anti-Infective Ophthalmic Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti-Infective Ophthalmic Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti-Infective Ophthalmic Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti-Infective Ophthalmic Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti-Infective Ophthalmic Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti-Infective Ophthalmic Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti-Infective Ophthalmic Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Infective Ophthalmic Industry Trends
  2. 2.2 Anti-Infective Ophthalmic Industry Drivers
  3. 2.3 Anti-Infective Ophthalmic Industry Opportunities and Challenges
  4. 2.4 Anti-Infective Ophthalmic Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Infective Ophthalmic Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Infective Ophthalmic Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Infective Ophthalmic Price (2021-2026)
  4. 3.4 Global Anti-Infective Ophthalmic Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Infective Ophthalmic Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Infective Ophthalmic Company, Product Type & Application
  7. 3.7 Global Anti-Infective Ophthalmic Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Infective Ophthalmic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Infective Ophthalmic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Infective Ophthalmic Tier 1, Tier 2, and Tier 3
4 Anti-Infective Ophthalmic Regional Status and Outlook
  1. 4.1 Global Anti-Infective Ophthalmic Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Infective Ophthalmic Historic Market Size by Region
  3. 4.2.1 Global Anti-Infective Ophthalmic Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Infective Ophthalmic Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Infective Ophthalmic Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Infective Ophthalmic Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Infective Ophthalmic Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Infective Ophthalmic Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Infective Ophthalmic Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Infective Ophthalmic by Application
  1. 5.1 Anti-Infective Ophthalmic Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Household
  5. 5.1.4 Others
  6. 5.2 Global Anti-Infective Ophthalmic Market Size by Application
  7. 5.2.1 Global Anti-Infective Ophthalmic Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-Infective Ophthalmic Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-Infective Ophthalmic Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-Infective Ophthalmic Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-Infective Ophthalmic Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-Infective Ophthalmic Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-Infective Ophthalmic Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Anti-Infective Ophthalmic Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Anti-Infective Ophthalmic Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Valeant Pharmaceuticals
  14. 6.3.1 Valeant Pharmaceuticals Company Information
  15. 6.3.2 Valeant Pharmaceuticals Business Overview
  16. 6.3.3 Valeant Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Valeant Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
  18. 6.3.5 Valeant Pharmaceuticals Recent Developments
  19. 6.4 Santen Pharmaceutical
  20. 6.4.1 Santen Pharmaceutical Company Information
  21. 6.4.2 Santen Pharmaceutical Business Overview
  22. 6.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolio
  24. 6.4.5 Santen Pharmaceutical Recent Developments
  25. 6.5 Lupin Pharmaceuticals
  26. 6.5.1 Lupin Pharmaceuticals Company Information
  27. 6.5.2 Lupin Pharmaceuticals Business Overview
  28. 6.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
  30. 6.5.5 Lupin Pharmaceuticals Recent Developments
  31. 6.6 Apotex
  32. 6.6.1 Apotex Company Information
  33. 6.6.2 Apotex Business Overview
  34. 6.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Apotex Anti-Infective Ophthalmic Product Portfolio
  36. 6.6.5 Apotex Recent Developments
  37. 6.7 Akorn
  38. 6.7.1 Akorn Company Information
  39. 6.7.2 Akorn Business Overview
  40. 6.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Akorn Anti-Infective Ophthalmic Product Portfolio
  42. 6.7.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Infective Ophthalmic Sales by Country
  2. 7.1.1 North America Anti-Infective Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Infective Ophthalmic Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Infective Ophthalmic Market Size by Country
  6. 7.2.1 North America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Infective Ophthalmic Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Infective Ophthalmic Sales by Country
  2. 8.1.1 Europe Anti-Infective Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Infective Ophthalmic Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Infective Ophthalmic Market Size by Country
  6. 8.2.1 Europe Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Infective Ophthalmic Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Infective Ophthalmic Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Infective Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Infective Ophthalmic Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Infective Ophthalmic Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Infective Ophthalmic Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Infective Ophthalmic Sales by Country
  2. 10.1.1 South America Anti-Infective Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Infective Ophthalmic Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Infective Ophthalmic Market Size by Country
  6. 10.2.1 South America Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Infective Ophthalmic Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Infective Ophthalmic Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Infective Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Infective Ophthalmic Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Infective Ophthalmic Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Infective Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Infective Ophthalmic Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Infective Ophthalmic Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Infective Ophthalmic Value Chain Analysis
  2. 12.1.1 Anti-Infective Ophthalmic Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Infective Ophthalmic Production Mode & Process
  7. 12.2 Anti-Infective Ophthalmic Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Infective Ophthalmic Distributors
  10. 12.2.3 Anti-Infective Ophthalmic Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst